規(guī)格:50μL/100μL
貨號(hào):PN0075
價(jià)格:1350元/50μL、2200元/100 μL
全稱 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 |
別名 | Amino acid transport system xc, CCBR1, Cystine/glutamate transporter, SLC7A11, SLC7A11/xCT, xCT |
抗體來源 | Rabbit |
克隆類型 | Polyclonal |
交叉反應(yīng) | Human(predicted: Human, Goat, Chicken) |
產(chǎn)品應(yīng)用 | WB : 1:500-1:2000 IHC : 1:50-1:500 IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate FC : 0.80 ug per 10^6 cells in a 100 μl suspension |
理論分子量 | 55kDa |
細(xì)胞定位 | 細(xì)胞膜 |
性 狀 | Liquid |
濃 度 | 500ug/ml |
免 疫 原 | SLC7A11/xCT fusion protein Ag25431 |
亞 型 | IgG |
純化方法 | affinity purified by Protein A |
Uniprot ID | |
緩 沖 液 | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
保存條件 | Store at -20°C. Stable for one year after shipment. |
注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
背景
SLC7A11 (also known as xCT) is a membrane transporter involved in the uptake of cystine. It promotes glutathione synthesis through the uptake of cystine and the concomitant release of glutamate. This, in turn, protects cells from oxidative stress, maintains cellμLar redox balance, and prevents cell death induced by lipid peroxidation. SLC7A11 has been identified as a potential target for cancer therapeutics. It is overexpressed in mμLtiple malignant tumors and is closely associated with the growth, prognosis, metastasis, and treatment response of various cancers including lung cancer. 26864-1-AP recognizes the 55 kDa and 35-40 kDa protein similar to the paper published (PMID: 32188872, 19156441).